A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma. - Bauer S; Larkin J; Hodi FS; Stephen F; Kapiteijn EHW; Schwartz GK; Calvo E; Yerramilli-Rao P; Piperno-Neumann S; Carvajal RD (Frontiers in oncology, 2023)